NDC 0615-8560 – Acamprosate Calcium
Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Oral
Product NDC0615-8560
Product details
- Brand name
- Acamprosate Calcium
- Generic name
- Acamprosate calcium enteric-coated
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Dosage form
- Tablet, Delayed Release
- Route
- Oral
- Marketing category
- ANDA · ANDA200142
- Marketed since
- September 24, 2014
- Marketing end
- October 31, 2026
Active ingredients
- Acamprosate Calcium 333 mg/1
Uses, dosage, side effects and warnings for Acamprosate Calcium →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0615-8560-39 | 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (0615-8560-39) | Feb 18, 2025 |
Other Acamprosate Calcium products
- 60687-121 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · American Health Packaging
- 69452-353 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Bionpharma Inc.,
- 68462-435 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Glenmark Pharmaceuticals Inc., USA
- 0904-7213 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Major Pharmaceuticals
- 0378-6333 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Mylan Pharmaceuticals Inc.
- 0615-8660 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · NCS HealthCare of KY, LLC dba Vangard Labs
- 70518-4616 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · REMEDYREPACK INC.
- 70069-860 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Somerset Therapeutics, LLC
- 70771-1057 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Zydus Lifesciences Limited
- 68382-569 Acamprosate Calcium 333 mg/1 · Tablet, Delayed Release · Zydus Pharmaceuticals (USA) Inc.